title: Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway.
abstract: DEC1 (BHLHB2)/Stra13/Sharp2, a basic helix-loop-helix (bHLH) transcription factor has been suggested to be involved in the control of proliferation and/or differentiation of several cells including nerve cells, fibroblasts and chondrocytes. In the present study, we examined the effect of parathyroid hormone (PTH), dibutyryl cAMP (Bt2cAMP) and forskolin on the expression of DEC1 in various cells. In rabbit chondrocyte cultures, PTH or Bt2cAMP increased the DEC1 mRNA level within 1 h. Thereafter, the DEC1 mRNA level rapidly decreased to the basal level at 3 h, and increased at 6-24 h. In cultures of a mouse embryo prechondrogenic cell line ATDC5, PTH or forskolin, an activator of adenylate cyclase, also increased the DEC1 mRNA level within 1 h. Furthermore, in all evaluated cell lines of human fibroblasts, canine epithelial cells, human carcinoma, human glioblastoma and human melanoma, Bt2cAMP increased the DEC1 mRNA level within 1-3 h. Studies with actinomycin D and cycloheximide indicated that the enhancement of DEC1 mRNA by cAMP was not due to mRNA stabilization and did not require new protein synthesis. These findings suggest that DEC1 is a novel direct target for cAMP in wide types of cells, and that the bHLH protein is involved in the control of gene expression in cAMP-activated cells.
authors: Department of Biochemistry, Hiroshima University Faculty of Dentistry, Japan.
authors: M
authors: M
authors: Shen
authors: T
authors: T
authors: Kawamoto
authors: M
authors: M
authors: Teramoto
authors: S
authors: S
authors: Makihira
authors: K
authors: K
authors: Fujimoto
authors: W
authors: W
authors: Yan
authors: M
authors: M
authors: Noshiro
authors: Y
authors: Y
authors: Kato
mesh_terms: D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins; D019902:Chondrocytes / Q000166:cytology; D000242:Cyclic AMP / Q000502:physiology*; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004285:Dogs; D005347:Fibroblasts / Q000166:cytology; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D005909:Glioblastoma; D006367:HeLa Cells; D018257:Helix-Loop-Helix Motifs / Q000502:physiology*; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D007668:Kidney / Q000166:cytology; D008168:Lung / Q000166:cytology; D008545:Melanoma; D051379:Mice; D008807:Mice, Inbred BALB C; D010281:Parathyroid Hormone / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D011817:Rabbits; D015398:Signal Transduction / Q000502:physiology*; D018243:Teratocarcinoma
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D000242:Cyclic AMP; D003513:Cycloheximide; D003609:Dactinomycin; D018398:Homeodomain Proteins; D010281:Parathyroid Hormone; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; C107989:BHLHE40 protein, human; C491539:Bhlhe40 protein, mouse